Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.700
-0.030 (-1.73%)
At close: Oct 30, 2025, 4:00 PM EDT
1.740
+0.040 (2.35%)
After-hours: Oct 30, 2025, 7:56 PM EDT

Coherus Oncology Statistics

Total Valuation

CHRS has a market cap or net worth of $197.59 million. The enterprise value is $978,368.

Market Cap197.59M
Enterprise Value 978,368

Important Dates

The next confirmed earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

CHRS has 116.23 million shares outstanding. The number of shares has increased by 6.04% in one year.

Current Share Class 116.23M
Shares Outstanding 116.23M
Shares Change (YoY) +6.04%
Shares Change (QoQ) +0.19%
Owned by Insiders (%) 4.32%
Owned by Institutions (%) 47.50%
Float 111.19M

Valuation Ratios

The trailing PE ratio is 1.09.

PE Ratio 1.09
Forward PE n/a
PS Ratio 0.72
Forward PS 2.47
PB Ratio 1.65
P/TBV Ratio 2.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.01
EV / Sales 0.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.34.

Current Ratio 1.44
Quick Ratio 1.36
Debt / Equity 0.34
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.63

Financial Efficiency

Return on equity (ROE) is 331.11% and return on invested capital (ROIC) is -29.48%.

Return on Equity (ROE) 331.11%
Return on Assets (ROA) -9.92%
Return on Invested Capital (ROIC) -29.48%
Return on Capital Employed (ROCE) -50.32%
Revenue Per Employee $1.19M
Profits Per Employee $788,382
Employee Count228
Asset Turnover 0.49
Inventory Turnover 3.61

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +128.68% in the last 52 weeks. The beta is 0.98, so CHRS's price volatility has been similar to the market average.

Beta (5Y) 0.98
52-Week Price Change +128.68%
50-Day Moving Average 1.51
200-Day Moving Average 1.10
Relative Strength Index (RSI) 54.09
Average Volume (20 Days) 1,007,452

Short Selling Information

The latest short interest is 30.17 million, so 25.95% of the outstanding shares have been sold short.

Short Interest 30.17M
Short Previous Month 31.14M
Short % of Shares Out 25.95%
Short % of Float 27.13%
Short Ratio (days to cover) 23.04

Income Statement

In the last 12 months, CHRS had revenue of $272.21 million and earned $179.75 million in profits. Earnings per share was $1.55.

Revenue272.21M
Gross Profit 151.86M
Operating Income -88.48M
Pretax Income 59.13M
Net Income 179.75M
EBITDA -83.83M
EBIT -88.48M
Earnings Per Share (EPS) $1.55
Full Income Statement

Balance Sheet

The company has $237.64 million in cash and $41.03 million in debt, giving a net cash position of $196.61 million or $1.69 per share.

Cash & Cash Equivalents 237.64M
Total Debt 41.03M
Net Cash 196.61M
Net Cash Per Share $1.69
Equity (Book Value) 119.83M
Book Value Per Share 1.03
Working Capital 116.58M
Full Balance Sheet

Cash Flow

Operating Cash Flow -105.87M
Capital Expenditures n/a
Free Cash Flow -105.87M
FCF Per Share -$0.91
Full Cash Flow Statement

Margins

Gross margin is 55.79%, with operating and profit margins of -32.50% and 66.03%.

Gross Margin 55.79%
Operating Margin -32.50%
Pretax Margin 21.72%
Profit Margin 66.03%
EBITDA Margin -30.80%
EBIT Margin -32.50%
FCF Margin n/a

Dividends & Yields

CHRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.04%
Shareholder Yield -6.04%
Earnings Yield 90.97%
FCF Yield -53.58%

Analyst Forecast

The average price target for CHRS is $4.51, which is 165.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.51
Price Target Difference 165.29%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) -2.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CHRS has an Altman Z-Score of -3.65 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.65
Piotroski F-Score 5